* Alimera Sciences Inc ALIM.OQ ALIM.O is expected
to show a
fall in quarterly revenue when it reports results on July 27.
* The Alpharetta Georgia-based company is expected to
report a
39.5% decrease in revenue to $13.137 million from $21.7 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Alimera Sciences
Inc is
for a loss of 55 cents per share. For the same quarter last
year, the company reported earnings of 72 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Alimera
Sciences
Inc is $11, above its last closing price of $5.41.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2022 -0.69 -0.69 -0.85 Missed -23.2
Dec. 31 2022 -0.41 -0.42 -0.59 Missed -40.5
Sep. 30 2021 -0.52 -0.52 -0.60 Missed -14.3
Jun. 30 2021 1.05 1.06 0.72 Missed -32.1
Mar. -0.52 -0.54 -0.63 Missed -16.7
31 2021
Dec. 31 2020 -0.04 -0.04 -0.18 Missed -315.4
Sep. 30 2020 -0.44 -0.44 -0.12 Beat 72.9
Jun. 30 2020 -1.09 -1.61 -0.51 Beat 68.4
This summary was machine generated July 25 at 13:42 GMT. All
figures in US dollars unless otherwise stated